InvestorsHub Logo
Followers 10
Posts 4272
Boards Moderated 0
Alias Born 11/12/2012

Re: grover13 post# 68252

Friday, 05/24/2013 11:55:59 PM

Friday, May 24, 2013 11:55:59 PM

Post# of 146242
The issues have all been covered before on this board. First, no human testing can be done until sufficient quantities of Flucide can be produced. It turns out that no conventional drug manufacturing plant can produce Flucide. So NNVC has had no option but to build their own manufacturing facility. This they are currently doing in Connecticut. It will probably be at least the end of this year, and maybe well into 2014, before they are manufacturing sufficient Flucide in the new plant for clinical trials. Second, they still have to do toxicity testing on Flucide. This is essential for any tests done in the U.S. Dr Feelgood/Synaptic Pruner/Whoever He Is Now claims that these tests are not required for doing clinical trials overseas. That may be correct, although I certainly wouldn't volunteer to take any experimental drug where they hadn't done the standard toxicity tests. The pre-IND meeting was completed in April 2012. Why, 13 months later, the tox tests haven't even been started is something I really don't understand. Anyhow, management claims they'll start in June +/- 3 months. So they might start as late as September. Or as soon as next week.

If you know anything about the history of this company you know that development has been glacially slow and they've missed many of their own deadlines. And that is why NNVC, whose product if it works could change the face of medicine, has a share price in the 0.60s.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News